<!DOCTYPE html><html><head><title> Pacifica Code Section 31A-46-S303 </title><link rel="stylesheet" href="../../../assets/style.css"/></head><body>
<b><i>
                      Effective 5/12/2020</i></b>
<br>
<b>31A-46-303.&nbsp;
          </b><b>Insurer and pharmacy benefit management services -- Registration -- Maximum allowable cost -- Audit restrictions.</b>
<br>
<a id="31A-46-303(1)" name="31A-46-303(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
An insurer and an insurer's pharmacy benefit manager is subject to the pharmacy audit provisions of Section <a href="../../Title58/Chapter17B/58-17b-S622.html?v=C58-17b-S622_2018050820180508">58-17b-622</a>.</td>
</tr>
</tbody></table>
<a id="31A-46-303(2)" name="31A-46-303(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
A pharmacy benefit manager shall not use maximum allowable cost as a basis for reimbursement to a pharmacy unless:
<a id="31A-46-303(2)(a)" name="31A-46-303(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
the drug is listed as "A" or "B" rated in the most recent version of the United States Food and Drug Administration's approved drug products with therapeutic equivalent evaluations, also known as the "Orange Book," or has an "NR" or "NA" rating or similar rating by a nationally recognized reference; and</td>
</tr>
</tbody></table>
<a id="31A-46-303(2)(b)" name="31A-46-303(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
the drug is:<a id="31A-46-303(2)(b)(i)" name="31A-46-303(2)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
generally available for purchase in this state from a national or regional wholesaler; and</td>
</tr>
</tbody></table>
<a id="31A-46-303(2)(b)(ii)" name="31A-46-303(2)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
not obsolete.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-46-303(3)" name="31A-46-303(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%">
The maximum allowable cost may be determined using comparable and current data on drug prices obtained from multiple nationally recognized, comprehensive data sources, including wholesalers, drug file vendors, and pharmaceutical manufacturers for drugs that are available for purchase by pharmacies in the state.</td>
</tr>
</tbody></table>
<a id="31A-46-303(4)" name="31A-46-303(4)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(4)</td><td style="width:99%">
For every drug for which the pharmacy benefit manager uses maximum allowable cost to reimburse a contracted pharmacy, the pharmacy benefit manager shall:
<a id="31A-46-303(4)(a)" name="31A-46-303(4)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
include in the contract with the pharmacy information identifying the national drug pricing compendia and other data sources used to obtain the drug price data;</td>
</tr>
</tbody></table>
<a id="31A-46-303(4)(b)" name="31A-46-303(4)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
review and make necessary adjustments to the maximum allowable cost, using the most recent data sources identified in Subsection <a href="#31A-46-303(4)(a)">(4)(a)</a>, at least once per week;</td>
</tr>
</tbody></table>
<a id="31A-46-303(4)(c)" name="31A-46-303(4)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
provide a process for the contracted pharmacy to appeal the maximum allowable cost in accordance with Subsection <a href="#31A-46-303(5)">(5)</a>; and</td>
</tr>
</tbody></table>
<a id="31A-46-303(4)(d)" name="31A-46-303(4)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
include in each contract with a contracted pharmacy a process to obtain an update to the pharmacy product pricing files used to reimburse the pharmacy in a format that is readily available and accessible.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-46-303(5)" name="31A-46-303(5)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(5)</td><td style="width:99%"><a id="31A-46-303(5)(a)" name="31A-46-303(5)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
The right to appeal in Subsection <a href="#31A-46-303(4)(c)">(4)(c)</a> shall be:<a id="31A-46-303(5)(a)(i)" name="31A-46-303(5)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
limited to 21 days following the initial claim adjudication; and</td>
</tr>
</tbody></table>
<a id="31A-46-303(5)(a)(ii)" name="31A-46-303(5)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
investigated and resolved by the pharmacy benefit manager within 14 business days.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-46-303(5)(b)" name="31A-46-303(5)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
If an appeal is denied, the pharmacy benefit manager shall provide the contracted pharmacy with the reason for the denial and the identification of the national drug code of the drug that may be purchased by the pharmacy at a price at or below the price determined by the pharmacy benefit manager.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-46-303(6)" name="31A-46-303(6)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(6)</td><td style="width:99%">
The contract with each pharmacy shall contain a dispute resolution mechanism in the event either party breaches the terms or conditions of the contract.</td>
</tr>
</tbody></table>
<a id="31A-46-303(7)" name="31A-46-303(7)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(7)</td><td style="width:99%">
This section does not apply to a pharmacy benefit manager when the pharmacy benefit manager is providing pharmacy benefit management services on behalf of the Medicaid program.</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=198&amp;sess=2020GS">198</a>, 2020 General Session<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=275&amp;sess=2020GS">275</a>, 2020 General Session<br>
</body></html>